Skip to search formSkip to main contentSkip to account menu

Metastatic Disease Clinical Trial Setting

Known as: METASTATIC 
A clinical trial or treatment setting in which the therapy of interest is used to treat metastatic disease.
National Institutes of Health

Related topics

Related topics

2 relations
CDISC SDTM Treatment Setting TerminologyClinical Data Interchange Standards Consortium Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Updated 2016 EAU Guidelines on Muscle-invasive and Metastatic Bladder Cancer.
Highly Cited
2017
Highly Cited
2017
Dabrafenib plus trametinib versus dabrafenib monotherapy in patients with metastatic BRAF V600E/K-mutant melanoma: long-term survival and safety analysis of a phase 3 study
Abstract Background Previous analysis of COMBI-d (NCT01584648) demonstrated improved progression-free survival (PFS) and overall… 
Highly Cited
2016
Highly Cited
2016
Response rates and durability of chemotherapy among 62 patients with metastatic Merkel cell carcinoma
Cytotoxic chemotherapy is commonly used to treat advanced Merkel cell carcinoma (MCC). However, its efficacy in distant… 
Highly Cited
2015
Highly Cited
2015
Survival with Newly Diagnosed Metastatic Prostate Cancer in the "Docetaxel Era": Data from 917 Patients in the Control Arm of the STAMPEDE Trial (MRC PR08, CRUK/06/019).
Highly Cited
2015
Highly Cited
2015
Cabazitaxel Remains Active in Patients Progressing After Docetaxel Followed by Novel Androgen Receptor Pathway Targeted Therapies.
Highly Cited
2014
Highly Cited
2014
Expanded access study of patients with advanced basal cell carcinoma treated with the Hedgehog pathway inhibitor, vismodegib.
Highly Cited
2013
Highly Cited
2013
Segmentation, Feature Extraction, and Multiclass Brain Tumor Classification
Multiclass brain tumor classification is performed by using a diversified dataset of 428 post-contrast T1-weighted MR images from… 
Highly Cited
2012
Highly Cited
2012
Outcome of children with metastatic medulloblastoma treated with carboplatin during craniospinal radiotherapy: a Children's Oncology Group Phase I/II study.
PURPOSE We evaluated the feasibility of administering carboplatin as a radiosensitizer during craniospinal radiation therapy… 
Highly Cited
2001
Highly Cited
2001
Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease
Little is known about the genetic regulation of medulloblastoma dissemination, but metastatic medulloblastoma is highly… 
Highly Cited
1991
Highly Cited
1991
Chemotherapy of metastatic and/or recurrent undifferentiated nasopharyngeal carcinoma with cisplatin, bleomycin, and fluorouracil.
Undifferentiated nasopharyngeal carcinoma (UCNT) is known to be radiosensitive and chemosensitive, but the latter has never been… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)